In hepatitis management, which common over-the-counter analgesic should be avoided due to liver metabolism concerns?

In hepatitis management, which common over-the-counter analgesic should be avoided due to liver metabolism concerns?

• A. Acetaminophen
• B. Ibuprofen
• C. Aspirin
• D. Naproxen

Answer: (A)

Acetaminophen should be avoided in hepatitis because it is processed by the liver into a toxic metabolite (NAPQI). When liver function is impaired or glutathione stores are depleted, NAPQI can accumulate and damage liver cells, increasing the risk of severe hepatotoxicity. While common NSAIDs like ibuprofen, aspirin, and naproxen have their own safety considerations, they do not create the same hepatotoxic metabolite pathway. Because of the specific risk to the liver, acetaminophen is the analgesic to avoid or limit in hepatitis management.

Acetaminophen should be avoided in hepatitis because it is processed by the liver into a toxic metabolite (NAPQI). When liver function is impaired or glutathione stores are depleted, NAPQI can accumulate and damage liver cells, increasing the risk of severe hepatotoxicity. While common NSAIDs like ibuprofen, aspirin, and naproxen have their own safety considerations, they do not create the same hepatotoxic metabolite pathway. Because of the specific risk to the liver, acetaminophen is the analgesic to avoid or limit in hepatitis management.